Analysts Bullish as Ventyx Biosciences (VTYX) Advances Its Clinical and Strategic Initiatives
On December 2, 2025, Ventyx Biosciences, Inc. (NASDAQ:VTYX) announced the addition of two prominent experts: Mark McKenna as Strategic Advisor and Dr. Peter Libby as Clinical Advisor.








